Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic Preservation
Top Cited Papers
- 4 May 2007
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 14 (6) , 1890-1895
- https://doi.org/10.1245/s10434-007-9412-x
Abstract
Variations in arm lymphatic drainage put the arm lymphatics at risk for disruption during axillary lymph node surgery. Mapping the drainage of the arm with blue dye (axillary reverse mapping, ARM) decreases the likelihood of disruption of lymphatics and subsequent lymphedema. This institutional review board (IRB)-approved study from May to October 2006 involved patients undergoing SLNB and/or ALND. Technetium sulfur colloid (4 mL) was injected in the subareolar plexus and 2–5 mL of blue dye intradermally was injected in the ipsilateral upper extremity (ARM). Data were collected on variations in lymphatic drainage that impacted SLNB or ALND, successful identification and protection of the arm lymphatics, any crossover between a hot breast node and a blue arm node, and occurrence of lymphedema. Of the 40 patients undergoing surgery for breast cancer, 18 required an ALND, with a median age of 49.7 years old. Fourteen patients had a SLNB + ALND, and four patients had ALND alone. In 100% of patients, all breast SLNs were hot but not blue, and the false negative rate was 0. In 11 of 18 ALNDs (61%) blue lymphatics or blue nodes were identified in the axilla. In the initial seven cases with positive lymph nodes in the axilla, the blue node draining from the arm was biopsied and all were negative. ARM identified significant lymphatic variations draining the upper extremities and facilitated preservation in all but one case. ARM added to present-day ALND and SLNB further defines the axilla and may be useful to prevent lymphedema.Keywords
This publication has 32 references indexed in Scilit:
- Breast Cancer-Related Lymphedema ? What Are the Significant Predictors and How They Affect the Severity of Lymphedema?The Breast Journal, 2006
- Lymphedema following axillary lymph node dissection for breast cancerSurgical Oncology, 2006
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI Journal of the National Cancer Institute, 2006
- Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group TrialAnnals of Surgical Oncology, 2006
- Comparative Morbidity of Axillary Lymph Node Dissection and the Sentinel Lymph Node TechniqueAnnals of Surgery, 2004
- Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast CancerArchives of Surgery, 2003
- Comparison of morbidity between axillary lymph node dissection and sentinel node biopsyEuropean Journal of Surgical Oncology, 2003
- Sentinel-Lymph-Node Biopsy for Breast Cancer — Not Yet the Standard of CareNew England Journal of Medicine, 1998
- The Use of Closed Suction Drainage After Lumpectomy and Axillary Node Dissection for Breast Cancer A Prospective Randomized TrialAnnals of Surgery, 1992
- Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breastBreast Cancer Research and Treatment, 1991